• 1226 Citations
  • 16 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

2019
4 Citations (Scopus)

A novel deep learning approach in haematology for classification of leucocytes

Bevilacqua, V., Brunetti, A., Trotta, G. F., De Marco, D., Quercia, M. G., Buongiorno, D., D’Introno, A., Girardi, F. & Guarini, A., Jan 1 2019, Smart Innovation, Systems and Technologies. Springer Science and Business Media Deutschland GmbH, p. 265-274 10 p. (Smart Innovation, Systems and Technologies; vol. 103).

Research output: Chapter in Book/Report/Conference proceedingChapter

Classifiers
Neural networks
Computer aided diagnosis
Lymphocytes
Backpropagation

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’

Mele, G., Pastore, D., Di Renzo, N., Fragasso, A., Guarini, A., Mazza, P., Musto, P., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Mele, A., Miccolis, M. R., Palazzo, G., Palumbo, G., Quinto, A. M., Reddiconto, G., Rizzi, R., Cascavilla, N., Specchia, G. & 1 others, Capalbo, S. F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma

Porcelli, L., Stolfa, D., Stefanachi, A., Di Fonte, R., Garofoli, M., Iacobazzi, R. M., Silvestris, N., Guarini, A., Cellamare, S. & Azzariti, A., Mar 31 2019, In : Cancer Letters. 445, p. 1-10 10 p.

Research output: Contribution to journalArticle

Antimitotic Agents
Hodgkin Disease
Tubulin
Cell Line
Microtubules
2018
6 Citations (Scopus)

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

Martino, M., Ciavarella, S., De Summa, S., Russo, L., Meliambro, N., Imbalzano, L., Gallo, G. A., Moscato, T., Messina, G., Ferreri, A., Cuzzola, M., Irrera, G., Naso, V., Cimminiello, M., Console, G., Loseto, G., Tommasi, S. & Guarini, A., Jan 30 2018, In : Biology of Blood and Marrow Transplantation. 24, 3, p. 608-613 6 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Multiple Myeloma
Inpatients
Outpatients
Quality of Life
2 Citations (Scopus)

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)

Pavone, V., Mele, A., Carlino, D., Specchia, G., Gaudio, F., Perrone, T., Mazza, P., Palazzo, G., Guarini, A., Loseto, G., Eleonora, P., Cascavilla, N., Scalzulli, P., Melpignano, A., Quintana, G., Di Renzo, N., Tarantini, G. & Capalbo, S., Oct 1 2018, In : Annals of Hematology. 97, 10, p. 1817-1824 8 p.

Research output: Contribution to journalArticle

Salvage Therapy
Life Change Events
Hodgkin Disease
Transplants
cAC10-vcMMAE

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

Ciavarella, S., Vegliante, M. C., Fabbri, M., De Summa, S., Melle, F., Motta, G., De Iuliis, V., Opinto, G., Enjuanes, A., Rega, S., Gulino, A., Agostinelli, C., Scattone, A., Tommasi, S., Mangia, A., Mele, F., Simone, G., Zito, A. F., Ingravallo, G., Vitolo, U. & 19 others, Chiappella, A., Tarella, C., Gianni, A. M., Rambaldi, A., Zinzani, P. L., Casadei, B., Derenzini, E., Loseto, G., Pileri, A., Tabanelli, V., Fiori, S., Rivas-Delgado, A., López-Guillermo, A., Venesio, T., Sapino, A., Campo, E., Tripodo, C., Guarini, A. & Pileri, S. A., 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, 12, p. 2363-2370 8 p.

Research output: Contribution to journalArticle

Cellular Microenvironment
Paraffin
Formaldehyde
Dissection
B-Lymphocytes

Improvable Lifestyle Factors in Lymphoma Survivors

Minoia, C., Ciavarella, S., Lerario, G., Daniele, A., De Summa, S., Napolitano, M. & Guarini, A., Aug 1 2018, In : Acta Haematologica. 139, 4, p. 235-237 3 p.

Research output: Contribution to journalArticle

Improvable Lifestyle Factors in Lymphoma Survivors

Minoia, C., Ciavarella, S., Lerario, G., Daniele, A., De Summa, S., Napolitano, M. & Guarini, A., Jun 22 2018, In : Acta Haematologica. 139, 4, p. 235-237 3 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project

Palandri, F., Benevolo, G., Iurlo, A., Abruzzese, E., Carella, A. M., Paoli, C., Palumbo, G. A., Bonifacio, M., Cilloni, D., Andriani, A., Guarini, A., Turri, D., Elli, E. M., Falcone, A., Anaclerico, B., Musto, P., Di Renzo, N., Tiribelli, M., Zambello, R., Spinosa, C. & 14 others, Ricco, A., Raucci, L., Martino, B., Annunziata, M., Pascale, S., Liberati, A. M., la Nasa, G., Maffioli, M., Breccia, M., Pugliese, N., Betti, S., Giglio, G., Cappuccio, A. & Reale, L., 2018, In : Quality of Life Research. 27, 6, p. 1545-1554 10 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Caregivers
Costs and Cost Analysis
Essential Thrombocythemia
Financial Support
4 Citations (Scopus)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

EMMOS Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Thalidomide
Cell Transplantation
Therapeutics
2017

Association between proteomic profile and molecular response in chronic myeloid leukemia patients

Garrisi, V. M., Sgherza, N., Breccia, M., Iacobazzi, A., De Tullio, G., Nardelli, G., Negri, A., Divella, R., Daniele, A., Micelli, G., Tufaro, A., Cascavilla, N., Savino, E., Abbate, I. & Guarini, A., Jul 11 2017, In : Leukemia and Lymphoma. p. 1-3 3 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Mar 1 2017, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents
4 Citations (Scopus)

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia

Mauro, F. R., Morabito, F., Vincelli, I. D., Petrucci, L., Campanelli, M., Salaroli, A., Uccello, G., Petrungaro, A., Ronco, F., Raponi, S., Nanni, M., Neri, A., Ferrarini, M., Guarini, A. R., Foà, R. & Gentile, M., 2017, In : Leukemia Research. 57, p. 65-71 7 p.

Research output: Contribution to journalArticle

Agammaglobulinemia
B-Cell Chronic Lymphocytic Leukemia
Infection
Immunoglobulin G
Immunoglobulin A
6 Citations (Scopus)

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial

Mauro, F. R., Carella, A. M., Molica, S., Paoloni, F., Liberati, A. M., Zaja, F., Belsito, V., Cortellezzi, A., Rizzi, R., Tosi, P., Spriano, M., Ferretti, A., Nanni, M., Marinelli, M., De Propris, M. S., Orlando, S. M., Vignetti, M., Cuneo, A., Guarini, A. R. & Foà, R., 2017, In : Leukemia and Lymphoma. 58, 7, p. 1640-1647 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Improving Provision of Care for Long-term Survivors of Lymphoma

Ciavarella, S., Minoia, C., Quinto, A. M., Oliva, S., Carbonara, S., Cormio, C., Cox, M. C., Bravo, E., Santoro, F., Napolitano, M., Spina, M., Loseto, G. & Guarini, A., Dec 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 12, p. e1-e9

Research output: Contribution to journalReview article

Survivors
Lymphoma
Survival Rate
Therapeutics
Muscular Atrophy
3 Citations (Scopus)

Improving Provision of Care for Long-term Survivors of Lymphoma

Ciavarella, S., Minoia, C., Quinto, A. M., Oliva, S., Carbonara, S., Cormio, C., Cox, M. C., Bravo, E., Santoro, F., Napolitano, M., Spina, M., Loseto, G. & Guarini, A., Dec 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 12, p. e1-e9 9 p.

Research output: Contribution to journalReview article

Survivors
Lymphoma
Survival Rate
Therapeutics
Muscular Atrophy
3 Citations (Scopus)

Improving Provision of Care for Long-term Survivors of Lymphoma

Ciavarella, S., Minoia, C., Quinto, A. M., Oliva, S., Carbonara, S., Cormio, C., Cox, M. C., Bravo, E., Santoro, F., Napolitano, M., Spina, M., Loseto, G. & Guarini, A., Dec 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 12, p. e1-e9

Research output: Contribution to journalReview article

Survivors
Lymphoma
Survival Rate
Therapeutics
Muscular Atrophy
30 Citations (Scopus)

Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis

Palmieri, E. M., Menga, A., Martín-Pérez, R., Quinto, A., Riera-Domingo, C., De Tullio, G., Hooper, D. C., Lamers, W. H., Ghesquière, B., McVicar, D. W., Guarini, A., Mazzone, M. & Castegna, A., Aug 15 2017, In : Cell Reports. 20, 7, p. 1654-1666 13 p.

Research output: Contribution to journalArticle

Glutamate-Ammonia Ligase
Macrophages
Tumors
T-cells
Neoplasm Metastasis
10 Citations (Scopus)

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

Ceriani, L., Martelli, M., Gospodarowicz, MK., Ricardi, U., Ferreri, AJ., Chiappella, A., Stelitano, C., Balzarotti, M., Cabrera, ME., Cunningham, D., Guarini, A., Zinzani, PL., Giovanella, L., Johnson, PW. & Zucca, E., 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
positrons
tomography
irradiation
progressions
10 Citations (Scopus)

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

Ceriani, L., Martelli, M., Gospodarowicz, M. K., Ricardi, U., Ferreri, A. J. M., Chiappella, A., Stelitano, C., Balzarotti, M., Cabrera, M. E., Cunningham, D., Guarini, A., Zinzani, P. L., Giovanella, L., Johnson, P. W. M. & Zucca, E., Jan 1 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
positrons
tomography
irradiation
progressions
6 Citations (Scopus)

u-PAR expression in cancer associated fibroblast: New acquisitions in multiple myeloma progression

Ciavarella, S., Laurenzana, A., De Summa, S., Pilato, B., Chillà, A., Lacalamita, R., Minoia, C., Margheri, F., Iacobazzi, A., Rana, A., Merchionne, F., Fibbi, G., Del Rosso, M., Guarini, A., Tommasi, S. & Serratì, S., Mar 24 2017, In : BMC Cancer. 17, 1, 11 p., 215.

Research output: Contribution to journalArticle

Multiple Myeloma
Plasminogen Activators
Urokinase-Type Plasminogen Activator
Cancer-Associated Fibroblasts
Bone Marrow
2016
7 Citations (Scopus)

A novel approach to evaluate blood parameters using computer vision techniques

Bevilacqua, V., Dimauro, G., Marino, F., Brunetti, A., Cassano, F., Di Maio, A., Nasca, E., Trotta, G. F., Girardi, F., Ostuni, A. & Guarini, A., Aug 4 2016, 2016 IEEE International Symposium on Medical Measurements and Applications, MeMeA 2016 - Proceedings. Institute of Electrical and Electronics Engineers Inc., 7533760

Research output: Chapter in Book/Report/Conference proceedingConference contribution

computer vision
Computer vision
blood
Blood
transfusion
3 Citations (Scopus)

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, G. A. & Morabito, F., Dec 6 2016, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Therapeutics
Maximum Tolerated Dose
Alkylating Agents
2 Citations (Scopus)

Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?

Minoia, C., Maggialetti, N., Ferrari, C., Brunese, L., Rubini, G. & Guarini, A., Jan 1 2016, In : Journal of B.U.ON.. 21, 1, p. 282-283 2 p.

Research output: Contribution to journalArticle

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: Multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Gentile, M., Zirlik, K., Ciolli, S., Mauro, F. R., Di Renzo, N., Mastrullo, L., Angrilli, F., Molica, S., Tripepi, G., Giordano, A., Di Raimondo, F., Selleri, C., Coscia, M., Musso, M., Orsucci, L., Mannina, D., Rago, A., Giannotta, A., Ferrara, F., Herishanu, Y. & 19 others, Shvidel, L., Tadmor, T., Scortechini, I., Ilariucci, F., Murru, R., Guarini, A., Musuraca, G., Mineo, G., Vincelli, I., Arcari, A., Tarantini, G., Caparrotti, G., Chiarenza, A., Levato, L., Villa, M. R., De Paolis, M. R., Zinzani, P., Polliack, A. & Morabito, F., Jun 1 2016, In : European Journal of Cancer. 60, p. 154-165 12 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
B-Cell Chronic Lymphocytic Leukemia
Therapeutics
Safety
Immunoglobulin Heavy Chains
11 Citations (Scopus)

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: Multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Gentile, M., Zirlik, K., Ciolli, S., Mauro, F. R., Di Renzo, N., Mastrullo, L., Angrilli, F., Molica, S., Tripepi, G., Giordano, A., Di Raimondo, F., Selleri, C., Coscia, M., Musso, M., Orsucci, L., Mannina, D., Rago, A., Giannotta, A., Ferrara, F., Herishanu, Y. & 19 others, Shvidel, L., Tadmor, T., Scortechini, I., Ilariucci, F., Murru, R., Guarini, A., Musuraca, G., Mineo, G., Vincelli, I., Arcari, A., Tarantini, G., Caparrotti, G., Chiarenza, A., Levato, L., Villa, M. R., De Paolis, M. R., Zinzani, P. L., Polliack, A. & Morabito, F., Jun 1 2016, In : European Journal of Cancer. 60, p. 154-165 12 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
B-Cell Chronic Lymphocytic Leukemia
Therapeutics
Safety
Immunoglobulin Heavy Chains

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: Multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials

Gentile, M., Zirlik, K., Ciolli, S., Mauro, F. R., Di Renzo, N., Mastrullo, L., Angrilli, F., Molica, S., Tripepi, G., Giordano, A., Di Raimondo, F., Selleri, C., Coscia, M., Musso, M., Orsucci, L., Mannina, D., Rago, A., Giannotta, A., Ferrara, F., Herishanu, Y. & 19 others, Shvidel, L., Tadmor, T., Scortechini, I., Ilariucci, F., Murru, R., Guarini, A., Musuraca, G., Mineo, G., Vincelli, I., Arcari, A., Tarantini, G., Caparrotti, G., Chiarenza, A., Levato, L., Villa, M. R., De Paolis, M. R., Zinzani, P., Polliack, A. & Morabito, F., Jun 1 2016, In : European Journal of Cancer. 60, p. 154-165 12 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
B-Cell Chronic Lymphocytic Leukemia
Therapeutics
Safety
Immunoglobulin Heavy Chains
2 Citations (Scopus)

Dasatinib first-line: Multicentric Italian experience outside clinical trials

Breccia, M., Stagno, F., Luciano, L., Abruzzese, E., Annunziata, M., D'Adda, M., Maggi, A., Sgherza, N., Russo-Rossi, A., Pregno, P., Castagnetti, F., Iurlo, A., Latagliata, R., Cedrone, M., Di Renzo, N., Sorà, F., Rege-Cambrin, G., La Nasa, G., Scortechini, A. R., Greco, G. & 10 others, Franceschini, L., Sica, S., Bocchia, M., Crugnola, M., Orlandi, E., Guarini, A., Specchia, G., Rosti, G., Saglio, G. & Alimena, G., 2016, In : Leukemia Research. 40, p. 24-29 6 p.

Research output: Contribution to journalArticle

Clinical Trials
Dasatinib
Safety
Leukemia, Myeloid, Chronic Phase
Blast Crisis

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M. M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia. 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M. M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia. 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase
7 Citations (Scopus)

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Latagliata, R., Stagno, F., Annunziata, M., Abruzzese, E., Iurlo, A., Guarini, A., Fava, C., Gozzini, A., Bonifacio, M., Sorà, F., Leonetti Crescenzi, S., Bocchia, M., Crugnola, M., Castagnetti, F., Capodanno, I., Galimberti, S., Feo, C., Porrini, R., Pregno, P., Rizzo, M. & 11 others, Antolino, A., Mauro, E., Sgherza, N., Luciano, L., Tiribelli, M., Russo Rossi, A., Trawinska, M., Vigneri, P., Breccia, M., Rosti, G. & Alimena, G., Sep 1 2016, In : Neoplasia (United States). 18, 9, p. 536-540 5 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Comorbidity
Dasatinib
Leukemia, Myeloid, Chronic Phase
3 Citations (Scopus)

Improvements in haematology for home health assistance and monitoring by a web based communication system

Galiano, A., Massaro, A., Boussahel, B., Barbuzzi, D., Tarulli, F., Pellicani, L., Renna, L., Guarini, A., De Tullio, G., Nardelli, G., Bonaduce, R., Minoia, C., Ciavarella, S., De Fazio, V., Negri, A. & Marchionna, C., Aug 4 2016, 2016 IEEE International Symposium on Medical Measurements and Applications, MeMeA 2016 - Proceedings. Institute of Electrical and Electronics Engineers Inc., 7533762

Research output: Chapter in Book/Report/Conference proceedingConference contribution

hematology
health
telecommunication
Communication systems
Health
12 Citations (Scopus)

Role of WB-MR/DWIBS compared to 18F-FDG PET/CT in the therapy response assessment of lymphoma

Maggialetti, N., Ferrari, C., Minoia, C., Asabella, A. N., Ficco, M., Loseto, G., De Tullio, G., de Fazio, V., Calabrese, A., Guarini, A., Rubini, G. & Brunese, L., Feb 1 2016, In : Radiologia Medica. 121, 2, p. 132-143 12 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Fluorodeoxyglucose F18
Lymphoma
Hodgkin Disease
Non-Hodgkin's Lymphoma

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program

Zinzani, P., Pellegrini, C., Cerciello, G., Monaco, F., Volpetti, S., Peli, A., Angelucci, E., Corradini, P., Cox, M. C., Guarini, A., Musso, M., Bresciani, P., Amato, G., Billio, A., Caparrotti, G., Figuera, A., Nassi, L., Gaudio, F., Grossi, A., Onida, F. & 3 others, Merli, M., Rigacci, L. & Argnani, L., Feb 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 57, 10, p. 2370-2374 5 p.

Research output: Contribution to journalArticle

T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Histone Deacetylase Inhibitors
Survival
Controlled Clinical Trials

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program

Zinzani, P., Pellegrini, C., Cerciello, G., Monaco, F., Volpetti, S., Peli, A., Angelucci, E., Corradini, P., Cox, M. C., Guarini, A., Musso, M., Bresciani, P., Amato, G., Billio, A., Caparrotti, G., Figuera, A., Nassi, L., Gaudio, F., Grossi, A., Onida, F. & 3 others, Merli, M., Rigacci, L. & Argnani, L., 2016, In : Leukemia and Lymphoma. 57, 10, p. 2370-2374 5 p.

Research output: Contribution to journalArticle

T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Histone Deacetylase Inhibitors
Survival
Controlled Clinical Trials

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program

Zinzani, P. L., Pellegrini, C., Cerciello, G., Monaco, F., Volpetti, S., Peli, A., Angelucci, E., Corradini, P., Cox, M. C., Guarini, A., Musso, M., Bresciani, P., Amato, G., Billio, A., Caparrotti, G., Figuera, A., Nassi, L., Gaudio, F., Grossi, A., Onida, F. & 3 others, Merli, M., Rigacci, L. & Argnani, L., Feb 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-5 5 p.

Research output: Contribution to journalArticle

T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Histone Deacetylase Inhibitors
Survival
Controlled Clinical Trials
2015
6 Citations (Scopus)

A supervised CAD to support telemedicine in hematology

Bevilacqua, V., Buongiorno, D., Carlucci, P., Giglio, F., Tattoli, G., Guarini, A., Sgherza, N., De Tullio, G., Minoia, C., Scattone, A., Simone, G., Girardi, F., Zito, A. & Gesualdo, L., Sep 28 2015, Proceedings of the International Joint Conference on Neural Networks. Institute of Electrical and Electronics Engineers Inc., Vol. 2015-September. 7280464

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Computer aided diagnosis
Telemedicine
Decision trees
Neural networks
Backpropagation

A voluminous mass as an initial clinical symptom of multiple myeloma: A case report

Sgherza, N., Iacobazzi, A., Cramarossa, A., De Tullio, G. & Guarini, A., Nov 1 2015, In : Experimental and Therapeutic Medicine. 10, 5, p. 1689-1691 3 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Plasma Cells
Bence Jones Protein
Biopsy
Hematology
4 Citations (Scopus)

Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: A multicenter case series

Minoia, C., Sgherza, N., Loseto, G., Greco, G., Buquicchio, C., Merchionne, F., Toldo, C., Galise, I., Melpignano, A., Tarantini, G., Pavone, V. & Guarini, A., Jan 1 2015, In : Anticancer Research. 35, 1, p. 461-466 6 p.

Research output: Contribution to journalArticle

Azacitidine
Second Primary Neoplasms
Therapeutics
Survival
Drug Therapy
4 Citations (Scopus)

Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP)

Delia, M., Carluccio, P., Buquicchio, C., Vergine, C., Greco, G., Amurri, B., Melpignano, A., Melillo, L., Cascavilla, N., Guarini, A., Capalbo, S., Tarantini, G., Mazza, P., Pavone, V., Di Renzo, N. & Specchia, G., Apr 22 2015, In : Leukemia Research. 39, 11, p. 1166-1171 6 p.

Research output: Contribution to journalArticle

Azacitidine
Acute Myeloid Leukemia
Bone Marrow
Treatment Failure
Therapeutics
18 Citations (Scopus)

Hepatocellular carcinoma treatment over sorafenib: Epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

Gnoni, A., Santini, D., Scartozzi, M., Russo, A., Licchetta, A., Palmieri, V., Lupo, L., Faloppi, L., Palasciano, G., Memeo, V., Angarano, G., Brunetti, O., Guarini, A., Pisconti, S., Lorusso, V. & Silvestris, N., Dec 2 2015, In : Expert Opinion on Therapeutic Targets. 19, 12, p. 1623-1635 13 p.

Research output: Contribution to journalArticle

MicroRNAs
Epigenomics
Tumors
Hepatocellular Carcinoma
Histone Deacetylase Inhibitors
1 Citation (Scopus)

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari

Lacalamita, R., Quaranta, A., Liuzzi, M. P. T., Nigro, A., Simonetti, U., Schirone, M., Aloè, F., Capochiani, G., De Francesco, G., Gadaleta, C., Galetta, D., Grammatica, L., Guarini, A., Mattioli, V., Milella, P., Moschetta, A., Nardulli, P., Nigro, V., Silvestris, N. & Paradiso, A., Dec 1 2015, In : Tumori. 101, p. S14-S18

Research output: Contribution to journalArticle

Accreditation
Neoplasms
Organizations
Benchmarking
Peer Review

αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: Basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations

De Tullio, G., Strippoli, S., Angarano, R., De Fazio, V., Sgherza, N., Negri, A., Albano, A., Iacopino, P., Guarini, A. & Guida, M., Jan 15 2015, (Accepted/In press) In : Journal of Translational Medicine. p. 1-3 3 p.

Research output: Contribution to journalArticle

2014
47 Citations (Scopus)

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: A GIMEMA Multicenter Phase II Trial

Cortelezzi, A., Sciumè, M., Liberati, A. M., Vincenti, D., Cuneo, A., Reda, G., Laurenti, L., Zaja, F., Marasca, R., Chiarenza, A., Gritti, G., Orsucci, L., Storti, S., Angelucci, E., Cascavilla, N., Gobbi, M., Mauro, F. R., Morabito, F., Fabris, S., Piciocchi, A. & 6 others, Vignetti, M., Neri, A., Rossi, D., Giannarelli, D., Guarini, A. & Foà, R., 2014, In : Leukemia. 28, 3, p. 642-648 7 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease-Free Survival
Confidence Intervals
Intention to Treat Analysis
Neutropenia
11 Citations (Scopus)

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: A retrospective analysis

Merchionne, F., Quintana, G., Gaudio, F., Minoia, C., Specchia, G., Guarini, A., Quarta, G., Pavone, V. & Melpignano, A., Dec 1 2014, In : Leukemia Research. 38, 12, p. 1446-1450 5 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Bendamustine Hydrochloride
Rituximab
Salvage Therapy
14 Citations (Scopus)

Challenges and opportunities of MicroRNAs in lymphomas

De Tullio, G., De Fazio, V., Sgherza, N., Minoia, C., Serratì, S., Merchionne, F., Loseto, G., Iacobazzi, A., Rana, A., Petrillo, P., Silvestris, N., Iacopino, P. & Guarini, A., Sep 17 2014, In : Molecules. 19, 9, p. 14723-14781 59 p.

Research output: Contribution to journalArticle

MicroRNAs
Lymphoma
Hematopoiesis
Therapeutics
Apoptosis
3 Citations (Scopus)

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities

L'Abbate, A., Lo Cunsolo, C., Macrì, E., Iuzzolino, P., Mecucci, C., Doglioni, C., Coco, M., Muscarella, L. A., Salati, S., Tagliafico, E., Minoia, C., De Tullio, G., Guarini, A., Testoni, N., Agostinelli, C. & Storlazzi, C. T., Jun 3 2014, In : BMC Cancer. 14, 1, 396.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Chromosome Aberrations
Chromosomes, Human, Pair 3
Mutation